百克生物：孙晚丰辞去公司第六届董事会职工代表董事、副总经理职务

Group 1 - The core point of the article is that Baike Biotechnology announced the resignation of Sun Wanfeng from his position as employee representative director and vice president, while he will continue to serve as assistant to the chairman [1] - Baike Biotechnology's revenue composition for the year 2024 is entirely from biopharmaceuticals, accounting for 100.0% [1] - As of the report, Baike Biotechnology has a market capitalization of 9.2 billion yuan [1]